Related Experiment Videos
Issues of choice in second-generation antipsychotic agents
1Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|October 17, 1998
Summary
Switching to second-generation antipsychotics requires careful monitoring to avoid confusing withdrawal with treatment failure, especially in patients with severe psychosis. This ensures optimal clinical use of these newer medications.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Second-generation antipsychotics (SGAs) represent advancements in treating psychosis.
- Optimal clinical use necessitates understanding potential challenges during treatment transitions.
Observation:
- A case report details an elderly female with treatment-refractory psychosis, negative symptoms, and tardive dyskinesia.
- The case highlights clinical decisions regarding switching antipsychotic medications.
Findings:
- Key considerations include the rationale for switching, selecting appropriate antipsychotic compounds, and managing the transition process.
- Careful monitoring during the switch from traditional to SGAs is crucial.
Implications:
- Distinguishing medication withdrawal from apparent treatment failure is vital for accurate assessment.
- This approach ensures effective management of severe psychiatric symptoms with second-generation antipsychotics.